Lobbying client · LD-2 disclosures
Exela Pharma Sciences
North Carolina
35 filings from 2 registrants · 2017–2024 · latest filed Oct 21, 2024
Reported on its behalf
$580K
every LD-2 on file
Its own filed spend
$0
lobbying for itself
Fees to outside firms
$580K
across every firm on file
Spend over time
Every filing period on record, as reported. One column per filed period — a period with no column is a period with no filing, not a zero.
Basis · Amendments and terminations supersede the original report for the same registrant, client and period, so a revised quarter is counted once at its latest filed value. Registration-only filings carry no activity money and are excluded from these totals.
Who lobbies for them
Every outside firm that has filed on this client's behalf, by fees reported.
What they lobby on
Issue areas declared on the filings, ranked by how many filings name each one.
Pharmacy
PHA
14 filings
$170K on those filings
Health Issues
HCR
7 filings
$390K on those filings
Note · A filing names one to several issue areas and reports a single dollar figure for the period, so the same money appears beside every issue that filing declares. The dollar column is therefore spend on filings that named this issue — it is not a split of the total, and these figures sum above it. Filing counts do not double-count.
Who did the lobbying
Every lobbyist named on this client's filings.
- William B Broydrick Broydrick & Associates15 filingsthrough 2021
- Terry Allen Fidelis Government RelationsCovered position: Chief of Staff, Rep. Steve Largent8 filingsthrough 2021
- Wayne King Fidelis Government RelationsCovered position: Deputy Chief of Staff, Rep. Mark Meadows8 filingsthrough 2021
- Samantha Dorsey Broydrick & Associates6 filingsthrough 2019
Covered positions · 2 of 4 lobbyists named on these filings disclosed a prior government post. The text is reproduced exactly as filed.
The filings
The 20 most recent of 35 filings. Every figure above is built from these records.
This record groups every filed spelling of the client's name into one entity, so "MERCK & CO., INC." and "MERCK & CO INC" read as the same company. The grouping is the client's normalized name — organizations that file under genuinely different names appear separately. Handle: exela-pharma-sciences.